... PAF-AH assay analysis.
From the pellet of the 1st centrifugation (leukocytes
and erythrocytes) the isolation of the leukocytes from
the contaminating erythrocytes was achieved by erythro-
cyte s edimentation. ... Taylor RR:
Platelet and plasma platelet- activating factor in sepsis and myocardial
infarction. J Lipid Mediat Cell Signal 1994, 9:167-182.
21. Ayala A, Chaudry IH:...
... Taylor RR:
Platelet and plasma platelet- activating factor in sepsis and myocardial
infarction. J Lipid Mediat Cell Signal 1994, 9:167-182.
21. Ayala A, Chaudry IH: Platelet activating factor and ... Tsoupras et al.: In vitro anti-inflammatory and anti-
coagulant effects of antibiotics towards Platelet Activating Factor and
thrombin. Journal of Infla...
... panel) and MMP-3 (Fig-
ure 10, middle panel). Successful inhibition of the caseinolytic
activity in zymography by EDTA and lack of inhibition by the
serine protease inhibitor phenylmethylsulfonyl ... the
induction of MMP-1 and MMP-3 in cartilage and SFB by TNF-
α and/ or IL-1β [42,43]. Therefore, they support the validity of
the new model for the analysis of the mechanisms...
... dysfunction. From our point of view, it may be not
only due to gland biosynthesis of abnormal hormone.
Tumour-produced hormones may not differ structurally
from their normal analogues. The dysfunctional ... theory as described by
Clark (1937) [3].
For example, kinetic schemes of such type were proved in
the case of estrogen regulation of gene expression [4],
apolipoprotein AI, CII,...
... Lipworth BJ: Systemic adverse effects of inhaled corticoster-
oid therapy: a systematic review and meta-analysis. Arch
Intern Med 1999, 159:941-955.
9. Newman SP: Deposition and effects of inhaled ... taken up by the cell. This may
explain the high portion of fatty acid esters of BUD at early
time points. FP, which has no free C-21 hydroxyl group,
was metabolically stable in t...
... any loss of efficiency after 12
hours of continuous use, and reached a steady state in terms
of temperature and humidity after only 15 min of use.
To improve the efficiency of HMEs, use of two ... commonly sug-
gested limits [1,2].
We also investigated the effects of severe hypothermia on
HME efficiency. We found that hypothermia markedly reduced
Figure 4
In vitro study...
... taken from healthy controls and sTBI patients were
determined by flow cytometry.
Materials and methods
To determine the potential stimulatory effects of norepine-
phrine on platelets, platelets were ... surgery.
Acta Anaesthesiol
Scand 2001, 45:449-457.
32. Hsiao G, Shen MY, Chou DS, Chang Y, Lee LW, Lin CH, Sheu JR:
Mechanisms of antiplatelet and antithrombotic activity of
mi...
... Hsu PC, Huang YT, Tsai ML, Wang YJ, Lin JK, Pan MH: Induction of
apoptosis by shikonin through coordinative modulation of
the Bcl-2 family, p27, and p53, release of cytochrome c, and
sequential ... control and cyclophosphamide and ace-
tylshikonin groups. Tumor volume of the mice in the
cyclophosphamide group increased slowly, suggesting
that the growth of LLC was suppressed...
... Effect of compounds on RT cell cycle profiles, and cell death were assessed by
MTS cell survival assays and FACS analysis. The effects of treatment on Cyclin D1
expression were determined by immunoblotting. ... of 4-HPR (5h and 5j) and peptidomimetic compounds (11a, 11c
and 11d).
Figure 3. Induction of cell cycle arrest by 4-HPR and its derivatives and
peptidomim...
... (extrinsically activation
by tissue factor) and FibTEM (extrinsically activation by
tissue f actor with addition of Cytochalasin D to inhibit
platelet function and display fibrin polymerization only -
all ... osmolarity of 300 mOsmol*l
-1
and an osmolarity of 2400 mOsmol*l
-1
for HyperHaes in
vitro dilution by 5% would suggest a resulting osmolar-
ity of appro ximately 405...